Global Autoimmune Disorders Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
SKU ID :GIR-13027234 | Published Date: 19-Oct-2018 | No. of pages: 128Description
Scope of the Report:
This report studies the Autoimmune Disorders Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autoimmune Disorders Treatment market by product type and applications/end industries.
Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on immune system.
The global Autoimmune Disorders Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Autoimmune Disorders Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bridge therapy
Recombinant technology
Fecal bacteriotherapy
Hematopoietic stem-cell transplantation
Phototherapy
Helminthic therapy
Activation-induced assays
Cytometry by time-of-flight mass spectrometry
Market Segment by Applications, can be divided into
Systemic autoimmune diseases
Localized autoimmune diseases
TOC
Tables & Figures
Companies
- PRICE
-
$3480$6960Buy Now